Tissue Regenix
Tissue Regenix Group plc is a medical technology company focused on developing and commercializing innovative products in tissue engineering and regenerative medicine. Founded in 2006 and based in Garforth, United Kingdom, the company operates globally, with a strong presence in the United States. Tissue Regenix utilizes its proprietary dCELL technology, a decellularization process that removes DNA and cellular material from biological tissues, thereby allowing the patient's cells to repopulate and create new, compatible tissue that minimizes rejection and promotes healing. The company’s diverse product portfolio includes offerings in BioSurgery, Orthopaedics, Dental, and Cardiac divisions. Key products include DermaPure, a decellularized dermal allograft; SurgiPure XD, a xenograft tissue for hernia repair; and various scaffold and bone matrix solutions designed to stimulate tissue regeneration. The underlying science for these technologies was developed at the Institute for Medical and Biological Engineering at the University of Leeds by leading researchers, further establishing Tissue Regenix as a pioneer in the field of regenerative medicine.
CellRight Technologies, LLC is a biotechnology company based in Universal City, Texas, specializing in the development and manufacturing of regenerative medicines and osteoinductive wound care scaffolds. Founded in 2011, the company focuses on creating products that enhance healing for defects caused by trauma and disease. CellRight is recognized as an industry leader in osteoinductive matrices, offering clinically verified implants that aim to improve patient outcomes and fusion rates. Their product range includes various graft options tailored for conventional and sports medicine, enabling healthcare providers to effectively deliver treatments such as platelet-derived growth factor, bone marrow aspirate, platelet-rich plasma, and antimicrobial agents. To ensure the efficacy of their products, CellRight conducts in-vivo and in-vitro testing for osteoinductivity through independent laboratories. As of 2017, the company operates as a subsidiary of Tissue Regenix Group plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.